CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Fluvoxamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 2 CEP/COS, 6 JDMF, 5 EU WC, 8 NDC API, 24 Listed Suppliers

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

148 FDF Dossiers, 65 FDA Orange Book, 48 Europe, 8 Canada, 20 Australia, 4 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 1 Rochem International Inc, 18 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 2 Kirsch Pharma, 1 Panvo Organics, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 1 Clariant, 17 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 2 Gloria Interchem, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 11 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 35 Controlled & Modified Release, 27 Direct Compression, 26 Solubilizers, 26 Thickeners and Stabilizers, 23 Disintegrants & Superdisintegrants, 23 Granulation, 22 Taste Masking, 21 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 17 Film Formers & Plasticizers, 16 Topical, 15 Parenteral, 14 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

15 News #PharmaBuzz

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 24 Regulatory FDF Prices

MARKET PLACE

16 APIs, 1 Intermediates

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 4 JP, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/03/2026	Cohance Lifesciences	India	COHANCE LIFESCIENCES LIMITED Mumbai IN	CEP 2014-089 - Rev 04	Fluvoxamine maleate	2024-09-27	Valid	Chemical		1977
31/03/2026	Lake Chemicals	India	LAKE CHEMICALS PRIVATE LIMITED Bengaluru IN	CEP 2024-047 - Rev 00	Fluvoxamine maleate	2026-02-02	Valid	Chemical		1977

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Fluvoxamine

Fluvoxamine

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

13 USDMF

2 CEP/COS

6 JDMF

5 EU WC

8 NDC API

24 Listed Suppliers

DEVELOPMENTS

7 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

148 FDF Dossiers

65 FDA Orange Book

48 Europe

8 Canada

20 Australia

4 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Evonik

1 Rochem International Inc

18 SPI Pharma

1 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

2 Kirsch Pharma

1 Panvo Organics

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

6 Actylis

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

26 BASF

1 Clariant

17 Corel Pharma Chem

3 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

2 Gloria Interchem

4 Ideal Cures

4 Ingredion Pharma Solutions

11 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

20 Roquette

14 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

CAPSULE, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons